Trial Profile
A double-blind placebo controlled randomised trial of oral sodium clodronate [clodronic acid] for locally advanced prostatic adenocarcinoma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Sep 2009
Price :
$35
*
At a glance
- Drugs Clodronic acid (Primary)
- Indications Cancer metastases; Prostate cancer
- Focus Therapeutic Use
- 01 Sep 2009 Long term overall survival results published in Lancet Oncology.
- 18 Aug 2006 New trial record.